コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 or Quil-A did not sensitize mice to M. bovis purified protein derivative.
2 e stimulated with DEP and M. tuberculosis or purified protein derivative.
3 zyme-linked immunospot responses against BCG purified protein derivative.
4 in greater numbers than T cells reactive to purified protein derivative.
5 red to responses induced by M. bovis-derived purified protein derivative.
6 following restimulation with M. tuberculosis purified protein derivative.
7 call antigen response by PBMCs to tuberculin purified protein derivative.
9 to MOG-35-55 peptide, and to a lesser degree purified protein derivative and Con A, but had no inhibi
10 L-2 production after both Mycobacteria bovis purified protein derivative and Schistosoma mansoni egg
11 +-T-cell activation than the soluble antigen purified protein derivative and that these cells are act
12 gamma release was significantly reduced when purified protein derivative- and Ag85B-specific CD4(+) T
13 d toward the rESAT-6-CFP10 fusion protein or purified protein derivative are comparable and that reca
14 uate its potential to replace tuberculin, or purified protein derivative, as the rapid diagnostic of
15 predictors of survival were found: anergy to purified protein derivative, atypical chest roentgenogra
17 NP-modified autologous melanoma cells and to purified protein derivative developed in almost all pati
20 in skin test, and (4) Battey skin test using purified protein derivative from the Battey bacillus.
21 memory cells specific for tetanus toxoid and purified protein derivative in 18 healthy individuals an
24 gens can overcome specificity limitations of purified protein derivatives in the detection of bovine
25 the expression of I kappa B-alpha mRNA, and purified protein derivative induced the activation of NF
26 Further, M. tuberculosis and its tuberculin, purified protein derivative, induced the degradation of
29 gamma response to Mycobacterium tuberculosis purified protein derivative (Mtb PPD) in UK adolescents,
33 nonuclear cells from 15/26 sarcoidosis, 1/24 purified-protein-derivative-negative (PPD-) (P < 0.0001,
34 ng 10 tuberculosis (TB)-infected subjects, 8 purified-protein-derivative-negative subjects, and 7 pur
39 ssociated with a reduced Mantoux response to purified protein derivative of M. tuberculosis: 60% of t
40 CBA mice by embolization of beads coupled to purified protein derivative of Mycobacteria tuberculosis
41 by embolizing Sepharose beads coupled to the purified protein derivative of Mycobacterium bovis or so
43 increased the in vitro cytokine responses to purified protein derivative of Mycobacterium tuberculosi
44 cells), much weaker than the response to the purified protein derivative of Mycobacterium tuberculosi
45 ayed-type hypersensitivity (DTH) response to purified protein derivative of tuberculin (PPD), the exp
46 cells specific for 2 other common antigens: purified protein derivative of tuberculin and Candida al
48 igated by T cell proliferation to tuberculin purified protein derivative or allogeneic responses to F
49 as induced by bead-immobilized mycobacterial purified protein derivative or Schistosoma mansoni egg a
50 nge of primed mice with either mycobacterial purified protein derivative or schistosomal egg Ag-coate
51 , unlike the mouse system, supernatants from purified protein derivative- or concanavalin A-stimulate
52 ensitized CBA/J mice with Mycobacteria bovis purified protein derivative- or Schistosoma mansoni egg
53 .v. challenge with either Mycobacteria bovis purified protein derivative- or Schistosoma mansoni egg
55 ure filtrate protein-10 (CFP10) are found in purified protein derivative positive donors, suggesting
56 absence of anti-LipC antibodies in sera from purified protein derivative-positive (PPD+) healthy subj
57 heral blood mononuclear cells of a number of purified protein derivative-positive (PPD+) human donors
60 in the context of host responses in healthy purified protein derivative-positive donors and infected
61 les for their ability to stimulate PBMC from purified protein derivative-positive healthy individuals
62 cited strong Th1 T cell responses in healthy purified protein derivative-positive human PBMC and in m
63 peripheral blood mononuclear cells in 70% of purified protein derivative-positive individuals without
65 e effector cell frequency among five healthy purified protein derivative-positive subjects was 1/7,60
66 ) TB(+) patients tested but not in sera from purified-protein derivative-positive healthy controls, s
68 a pigs were frequently identified in healthy purified-protein-derivative-positive or BCG-vaccinated i
70 y peripheral blood leukocytes after M. avium purified protein derivative PPD antigen stimulation show
71 with the stability of skin test responses to purified protein derivative (PPD) and candida antigens i
72 /chemokine microenvironment before and after purified protein derivative (PPD) and mannosilated lipoa
73 Whole-blood samples were stimulated with purified protein derivative (PPD) and phytohemagglutinin
74 pathogen antigens (Ags), Mycobacteria bovis purified protein derivative (PPD) and Schistosoma manson
75 dritic cells infected with TB or pulsed with purified protein derivative (PPD) but did not respond to
76 aradoxical responses and received tuberculin purified protein derivative (PPD) in Group 1 had their t
77 lar lavage (BAL) fluid after incubation with purified protein derivative (PPD) in human immunodeficie
79 Brugia malayi antigen (BMA) or mycobacterial purified protein derivative (PPD) in the presence of neu
82 To investigate this, we injected tuberculin purified protein derivative (PPD) into the skin of immun
84 ) HIV-seronegative patients had reactions to purified protein derivative (PPD) of > or = 2 mm (OR = 0
85 ranulomas were elicited by beads coated with purified protein derivative (PPD) of Mycobacteria bovis
86 ced by embolizing Sepharose beads coupled to purified protein derivative (PPD) of Mycobacterium bovis
87 d mice by embolization with beads coupled to purified protein derivative (PPD) of Mycobacterium bovis
88 We have used human CD4+ T cells specific for purified protein derivative (PPD) of Mycobacterium tuber
90 -vaccinated guinea pigs were stimulated with purified protein derivative (PPD) or M. tuberculosis H37
91 nfected cattle were stimulated with M. bovis purified protein derivative (PPD) or pokeweed mitogen (P
92 m HIV-infected individuals with a history of purified protein derivative (PPD) positivity but not in
93 s were cocultured with autologous T-Regs and purified protein derivative (PPD) preprimed T-Reg-deplet
94 tive therapy trial in Uganda with an initial purified protein derivative (PPD) response < 5 mm comple
95 accination may induce persistent and booster purified protein derivative (PPD) responses that complic
96 11 (17%) of 66 with a history of a positive purified protein derivative (PPD) skin test acquired M.
99 ination, laboratory evaluation, and standard purified protein derivative (PPD) testing (Mantoux metho
101 cobacterium avium sensitin (MAS) RS 10/2 and purified protein derivative (PPD) was conducted on patie
102 human experimental system whereby tuberculin purified protein derivative (PPD) was injected into the
104 l myristate acetate (PMA) plus ionomycin, or purified protein derivative (PPD) was studied in vitro.
105 une response, elicited by Mycobacteria bovis purified protein derivative (PPD) was unaffected by CCR8
107 lin skin tests (induration, > or =5 mm) with purified protein derivative (PPD) were randomly assigned
108 because of the antigenic cross-reactivity of purified protein derivative (PPD) with M bovis BCG vacci
110 coidosis patients compared with 0 of 11 (0%) purified protein derivative (PPD)(-) (P = 0.0059) and 4
112 have long been detected by skin testing with purified protein derivative (PPD), a complex mix of part
113 TH to vaccine (P =.0001) but not with DTH to purified protein derivative (PPD), a control antigen.
115 ed in response to the mycobacterial antigens purified protein derivative (PPD), antigen 85, and manno
116 osis of both active and latent tuberculosis, purified protein derivative (PPD), lacks specificity and
117 pment of pulmonary granulomas in response to purified protein derivative (PPD), mice presensitized to
118 une competence was assessed by skin tests to purified protein derivative (PPD), mumps, and candida.
119 overnight in separate wells with tuberculin purified protein derivative (PPD), saline, and mitogen c
120 y (DTH) reaction to intradermal injection of purified protein derivative (PPD), we investigated the e
121 significantly augment the mycobacterial Ag, purified protein derivative (PPD)-driven lymphocyte prol
123 d HIV-positive, TB-positive patients but not purified protein derivative (PPD)-negative or PPD-positi
124 In contrast, nonadherent cells (NAC) from purified protein derivative (PPD)-positive and PPD-negat
125 th MDRTB were compared with those of healthy purified protein derivative (PPD)-positive and PPD-negat
126 Natural killer (NK) cells isolated from both purified protein derivative (PPD)-positive and PPD-negat
128 ted for their ability to stimulate PBMC from purified protein derivative (PPD)-positive healthy donor
129 y approximately 50% when compared to healthy purified protein derivative (PPD)-positive household con
130 blood mononuclear cells (PBMC) from healthy purified protein derivative (PPD)-positive individuals o
132 isease coincided with the restoration of BCG purified protein derivative (PPD)-specific T-cell immune
136 uring both the 2-wk immunization period with purified protein-derivative (PPD) and the subsequent lun
137 77 years, HIV-1 seropositive, had a positive purified-protein derivative (PPD) skin test reaction of
138 ntigen and 2 tuberculosis-specific antigens (purified protein derivative [PPD] and ESAT-6/CFP10), fol
139 isease, and (iii) M. tuberculosis infection (purified protein derivative [PPD] positive) and no infec
144 en both vaccines were administered together, purified protein derivative responses were enhanced in f
145 cells from healthy donors who had a positive purified protein derivative skin test but not from tuber
148 cells coincided with increases in numbers of purified protein derivative-specific interferon- gamma -
150 f IFN-gamma ELISPOT responses to recall Ags (purified protein derivative, Tetanus toxoid, or flu/EBV/
151 ovirus during the sensitization phase of the purified protein derivative Th1-type model significantly
152 and IL-12 were significantly reduced in the purified protein derivative Th1-type response, whereas I
153 more IFN-gamma in response to mycobacterial purified protein derivative than children of helminth-in
154 r recall Ags (influenza, n = 43, p < 0.0001; purified protein derivative tuberculin, n = 6, p = 0.029
155 d immune responses to mycobacterial antigen (purified protein derivative) were assayed using splenocy
156 enic target 6 (ESAT6) protein or tuberculin (purified protein derivative) with interferon-gamma ELISP
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。